Abstract:July 2020 1 Chengjie Gao, MD Jingwei Pan , PhD Jingbo Li, PhD A 50-year-old man presented to the local emergency room complaining of palpitation and episodes of syncope with no chest pain or dyspnea. Successful synchronous cardioversion was performed with 150 J DC shock, but sinus rhythm could not be maintained. The patient was conscious while being transferred to our cardiac center. ECG revealed unremittent ventricular tachycardia (VT) with heart rate up to 200 bpm (Figure 1). Sustained micro-pump amiodarone could convert VT to sinus rhythm (40–45 bpm), but it was not persistent. Transthoracic echocardiography showed global left ventricular (LV) hypokinesia with LV ejection fraction of 40% (Movies I, II, and III in the Data Supplement). The patient gave history of type B preexcitation syndrome 4 years ago, which was radiofrequency ablated successfully. His father encountered sudden death with unknown specific cause. Coronary angiography showed no significant stenosis of coronary artery and normal left ventricular end diastolic pressure of 2 mm Hg. During electrophysiology study, although the pacing ECG was identical to the patient’s spontaneous VT ECG, activation mapping showed local electrogram was 41 ms ahead of QRS wave from surface ECG and perfect QS pattern unipolar electrogram was got (Figure 2). As invalid radiofrequency catheter ablation of right ventricle (RV) outflow anterior septum, further cardiac magnetic resonance was performed, which showed thickened interventricular septum with extensive fibrosis (Figure 3A), global biventricular hypokinesia with LV ejection fraction declined to 38%, right ventricular ejection fraction to 30% (Movie IV in the Data Supplement). Arrhythmogenic right ventricular cardiomyopathy (ARVC) was diagnosed according to The European Society of Cardiology Task Force Criteria revised in 2010,1 major category of diagnostic criteria for ARVC was summarized briefly in (Table). Implantable cardioverter defibrillator was implanted to prevent episodes of VT. To further understand the cause of the disease, we subsequently applied whole exon sequencing technology for the patient and his 2 sons (Figure 4). The patient (I-2) was identified to carry 2 rare missense mutations, RYR2 (ryanodine receptor type 2) c.1509C>A (p.D503E) and AKAP10 c.1362T>G (p.D454E). The 2 single nucleotide variants were susceptible to ARVC type 2, catecholaminergic polymorphic VT type 1, and cardiac conduction defect, but none had been reported the correlation with ARVC family before. Unfortunately, the older son (II-1) was detected the same 2 single nucleotide variant and impaired biventricular function by cardiac magnetic resonance (Movie V in the Data Supplement). This case presents a man of refractory electrical storm caused by biventricular involved ARVC. Unremittent VT could not be terminated by drug with reduced biventricular function. The VT was mono-morphology and originated from the anterior septum of RV outflow. Although the pacing ECG was identical to the patient’s spontaneous VT ECG and ablation spot was optimum, incessant VT © 2020 American Heart Association, Inc. CARDIOVASCULAR IMAGES

Escalation of Mechanical Circulatory Support in a Patient with an Acute Myocardial Infarction, Cardiogenic Shock and Refractory Ventricular Tachycardia

Impact of mechanical circulatory support on in‐hospital outcomes among patients with ventricular tachycardia requiring ablation

Mechanical circulatory support as bridge to recovery in an 8-year-old girl with tachycardia-induced cardiomyopathy due to atypical atrioventricular nodal re-entrant tachycardia: a case report

Case report: Successful percutaneous extracorporeal magnetic levitation ventricular assist device support in a patient with left heart failure due to dilated cardiomyopathy

Hypovolemic Shock And The Need For Invasive Mechanical Ventilation On A Patient With Congenital Heart Disease

Prolonged Impella® 5.5 Utilization As A Bridge To Destination (btd) In A Patient With End-stage Heart Failure

Complication Rates Of Temporary Mechanical Circulatory Support In Patients With Cardiogenic Shock

[Early experience with mechanical hemodynamic support for catheter ablation of malignant ventricular tachycardia]

Percutaneous mechanical support in catheter ablation of ventricular arrhythmias: hype or hope?

Severe mitral stenosis masquerading as cardiogenic shock successfully managed with extracorporeal membrane oxygenation and percutaneous mitral commissurotomy: a case report

Discussion of hemodynamic optimization strategies and the canonical understanding of hemodynamics during biventricular mechanical support in cardiogenic shock: does the flow balance make the difference?

Mechanical circulatory support for cardiogenic shock during the peripartum period

Extending the window in clinical decision making: the role for Impella 5.5 in cardiogenic shock

Refractory Electrical Storm in a 50-Year-old Man.

The Use of Mechanical Circulatory Assist Devices for ACS Patients with Cardiogenic Shock and High-Risk PCI

Short-term mechanical circulatory support in adults with congenital heart disease: indications and outcomes

Mechanical circulatory support in cardiogenic shock patients

Delayed Closure of Ventricular Septal Defect with Prolonged Mechanical Support

Therapeutic Management of VA-ECMO Support for Cardiogenic Shock: Case Report.

Trends and outcomes of different mechanical circulatory support modalities for acute myocardial infarction associated cardiogenic shock in patients undergoing early revascularization

Experience with percutaneous right ventricular support in the early post-left ventricular assist device implantation period (clinical case report and literature reviews)